Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of Prescription Omega-3 Fatty Acid Added to Stable Statin Therapy in Patients With Type 2 Diabetes and Hypertriglyceridemia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* LDL-C \< 100mg/dL, TG \> 150mg/dL, patients on statin treatment for at least 6 weeks prior to randomization.~* Type 2 Diabetes~* HbA1c ≤ 10.0~Exclusion Criteria:~* Type 1 Diabetes~* Patients with PPAR gamma agonist therapy~* Patients with acute MI, Unstable angina within 6 months~* History of malignant tumor within 2 years~* Women with pregnant, breast-feeding

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Omega-3-acids ethylesters 90 4g, any statin (Type: EXPERIMENTAL): None
- any statin (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).